1999
Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load
Rompalo A, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg S, Warren D, Farzadegan H, Vlahov D, Smith D. Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 448-454. PMID: 10225226, DOI: 10.1097/00042560-199904150-00006.Peer-Reviewed Original ResearchConceptsHIV-1 viral loadPlasma viral loadBody mass indexHIV-1 plasma viral loadOral hairy leukoplakiaInjection drug useViral loadInjection drug usersRisk groupsHIV infectionCell countDrug useHairy leukoplakiaCells/Clinical manifestationsHeterosexual contactMedian HIV-1 viral loadPlasma HIV-1 viral loadUndetectable HIV-1 viral loadPlasma viral load levelsHIV viral loadIntravenous drug useViral load levelsPopulation of HIVPrevalence of HIV
1996
Alcohol Use and T‐Lymphocyte Subsets among Injection Drug Users with HIV‐1 Infection: A Prospective Analysis
Crum R, Galai N, Cohn S, Celentano D, Vlahov D. Alcohol Use and T‐Lymphocyte Subsets among Injection Drug Users with HIV‐1 Infection: A Prospective Analysis. Alcohol Clinical And Experimental Research 1996, 20: 364-371. PMID: 8730231, DOI: 10.1111/j.1530-0277.1996.tb01654.x.Peer-Reviewed Original ResearchConceptsInjection drug usersCohort of IDUsT lymphocyte subsetsDrinks/weekHIV seroconversionAlcohol useYears postseroconversionDrug usersAlcohol categoriesHIV-positive injection drug usersCD8 absolute countsHIV-1 seroconvertersProgression of immunodeficiencyLevels of CD4Intravenous drug useT lymphocyte subpopulationsFirst prospective studyHIV-1 infectionTime of seroconversionSignificant differencesEarly intervention programsHIV infectionHIV progressionOutpatient clinicProspective study
1994
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson K. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal Of Public Health 1994, 84: 382-7. PMID: 8129052, PMCID: PMC1614821, DOI: 10.2105/ajph.84.3.382.Peer-Reviewed Original ResearchConceptsFemale intravenous drug usersIntravenous drug usersHIV seropositivityHIV infectionDrug usersHuman immunodeficiency virus (HIV) seroprevalenceIntravenous drug useDrug-using womenTrading of sexCohort studyVirus seroprevalenceDrug useCocaine useIntensive interventionLogistic regressionSeropositivityNumber of partnersMultivariate modelDrugsWomenSexInfectionGroupHigh levelsSeroprevalenceComparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users
Schültz C, Vlahov D, Anthony J, Graham N. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. Journal Of Clinical Epidemiology 1994, 47: 191-195. PMID: 8113828, DOI: 10.1016/0895-4356(94)90024-8.Peer-Reviewed Original Research
1993
Comparison of Clinical Symptoms of Human Immunodeficiency Virus Disease Between Intravenous Drug Users and Homosexual Men
Palenicek J, Nelson K, Vlahov D, Galai N, Cohn S, Saah A. Comparison of Clinical Symptoms of Human Immunodeficiency Virus Disease Between Intravenous Drug Users and Homosexual Men. JAMA Internal Medicine 1993, 153: 1806-1812. PMID: 8101438, DOI: 10.1001/archinte.1993.00410150094009.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell levelsClinical symptomsDrug usersHomosexual menOral candidiasisHIV infectionPhysical examinationRisk groupsMale intravenous drug usersHuman immunodeficiency virus (HIV) diseaseRisk behavior interviewsCD4 cell countTotal lymphocyte countIntravenous drug useShortness of breathMost clinical symptomsHIV-1 infectionHuman immunodeficiency virusFrequency of symptomsIntermediate outcome measuresCell levelAbnormal hematocritHIV immunosuppressionNight sweatsDifferences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users
Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson K. Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users. American Journal Of Epidemiology 1993, 137: 892-898. PMID: 8484380, DOI: 10.1093/oxfordjournals.aje.a116750.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionDrug usersSeronegative controlsRisk factorsFemale intravenous drug usersMale intravenous drug usersSex-specific risk factorsCurrent intravenous drug useHIV-seronegative controlsIntravenous drug useRisk of seroconversionRisk factor dataCase-control studyAge 18 yearsConditional logistic regression techniquesTime of interviewMore sex partnersSeroconversion statusSeroconversion visitHIV seroconversionHIV infectionStudy entrySexual transmissionSeroconversion
1992
HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects.
Selnes O, McArthur J, Royal W, Updike M, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992, 42: 1924-30. PMID: 1407574, DOI: 10.1212/wnl.42.10.1924.Peer-Reviewed Original ResearchConceptsIntravenous drug usersIntravenous drug useDrug usersHIV infectionSerostatus groupsHIV-seropositive intravenous drug usersDrug useHIV-1 infectionHigh-risk groupRoute of acquisitionLongitudinal neuropsychological evaluationCross-sectional comparisonPreexisting deficitAsymptomatic subjectsLongitudinal followAdditional cognitive impairmentPresymptomatic stageNeurocognitive abnormalitiesCognitive impairmentNeuropsychological evaluationNeuropsychological deficitsSame cohortBisexual menInfectionSignificant differencesCharacteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use
ALCABES P, VLAHOV D, ANTHONY J. Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use. The Journal Of Nervous And Mental Disease 1992, 180: 48-54. PMID: 1311371, DOI: 10.1097/00005053-199201000-00010.Peer-Reviewed Original ResearchTerminology for Drug Injection Practices among Intravenous Drug Users in Baltimore
Smith A, Vlahov D, Menon A, Anthony J. Terminology for Drug Injection Practices among Intravenous Drug Users in Baltimore. Substance Use & Misuse 1992, 27: 435-453. PMID: 1563894, DOI: 10.3109/10826089209068752.Peer-Reviewed Original ResearchConceptsDrug injection practicesIntravenous drug usersInjection practicesDrug usersDrug useIntravenous drug useInjection of drugsMedian durationHIV infectionMedian ageSubcutaneous injectionOwn bloodDrug experienceLongitudinal studyInjectionDrugsUseful aidDifferent syringesDurationBaltimoreYearsInfectionBloodHIV INFECTION AND AIDS AMONG U.S. PRISON INMATES
Behrendt C, Vlahov D, Clark J, Kendig N. HIV INFECTION AND AIDS AMONG U.S. PRISON INMATES. Journal Of Crime And Justice 1992, 15: 173-186. DOI: 10.1080/0735648x.1992.9721458.Peer-Reviewed Original ResearchHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useVoluntary HIV testingOnset of AIDSCause of deathRisk reduction programsHIV infectionHIV testingHIV-positiveImmunodeficiency syndromeHigh prevalenceVirus infectionHigh riskGeneral populationElevated incidenceDrug usePrison inmatesTesting treatmentsHealth careAIDSState prison systemInfectionTreatmentMore researchBacterial infections and skin cleaning prior to injection among intravenous drug users.
Vlahov D, Sullivan M, Astemborski J, Nelson K. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Reports 1992, 107: 595-8. PMID: 1410243, PMCID: PMC1403704.Peer-Reviewed Original ResearchPrognostic indicators for development of AIDS among intravenous drug users.
Muñoz A, Vlahov D, Solomon L, Margolick J, Bareta J, Cohn S, Astemborski J, Nelson K. Prognostic indicators for development of AIDS among intravenous drug users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 694-700. PMID: 1613668.Peer-Reviewed Original ResearchConceptsCD4 cell countIntravenous drug usersClinical symptomsDrug usersCell countHigher CD4 cell countsHIV-1-related symptomsSeropositive intravenous drug usersPneumocystis carinii prophylaxisIntravenous drug useDevelopment of AIDSDose-response relationshipYear of enrollmentSerum neopterinLaboratory markersSerum betaPrognostic indicatorClinical evaluationAntiviral agentsRelative hazardDrug useSurvival analysisMultivariate analysisSignificant associationAIDS
1991
Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland
Donahue J, Nelson K, Mufioz A, Vlahov D, Rennie L, Taylor E, Saah A, Cohn S, Odaka N, Farzadegan H. Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland. American Journal Of Epidemiology 1991, 134: 1206-1211. PMID: 1720924, DOI: 10.1093/oxfordjournals.aje.a116023.Peer-Reviewed Original ResearchConceptsHepatitis C virusIntravenous drug useIntravenous drug usersC virusHepatitis CDrug usersDrug useHuman immunodeficiency virus (HIV) infectionHepatitis C seropositiveHepatitis C seropositivityHIV-1 statusCardiac surgery patientsImmunodeficiency virus infectionIncidence of antibodiesMulti-transfused patientsSexual behavior variablesC seropositivitySurgery patientsCardiac surgeryHepatitis AProspective studyRisk factorsBlood exposureVirus infectionHIV-1
1990
HIV-1 Infection In The Correctional Setting
Vlahov D. HIV-1 Infection In The Correctional Setting. Criminal Justice Policy Review 1990, 4: 306-318. DOI: 10.1177/088740349000400402.Peer-Reviewed Original ResearchHIV infectionMajor public health problemIntravenous drug useHIV-1 infectionCause of deathPublic health problemHIV ratesSeroprevalence estimatesDrug useHealth problemsRisk behaviorsInfectionJail settingsCorrectional settingsLimited accessPrison inmatesPercentEthnic minoritiesAIDSCorrectional systemSettingCareBlood and Plasma Donations Among a Cohort of Intravenous Drug Users
Nelson K, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. JAMA 1990, 263: 2194-2197. PMID: 1969502, DOI: 10.1001/jama.1990.03440160056037.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seroprevalenceIntravenous drug useDrug usersHuman immunodeficiency virus serologic statusDrug useHIV test resultsCD4 lymphocytesEntire cohortPeripheral bloodSerologic statusDonor poolIntravenous drugsHIV-1Blood donationMost subjectsPlasma donationBloodCohortDonation historySeroprevalenceDonationLymphocytesHistoryPlasmaAssociation between intravenous drug use and early misbehavior
Tomas J, Vlahov D, Anthony J. Association between intravenous drug use and early misbehavior. Drug And Alcohol Dependence 1990, 25: 79-89. PMID: 2323313, DOI: 10.1016/0376-8716(90)90145-5.Peer-Reviewed Original ResearchConceptsIntravenous drug useDrug useDrug usersConditional logistic regression modelsEarly lifeHIV-1 infectionPublic health strategiesIllicit drug useLogistic regression modelsHealth strategiesNatural historyEpidemiologic strategiesStrong associationUnit increaseScoresAssociationRegression modelsSubjectsSubsequent involvementHigher scoresCensus tractsInfectionAIDSDegree of associationTract
1989
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987.
Vlahov D, Brewer F, Muñoz A, Hall D, Taylor E, Polk B. Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 283-90. PMID: 2786071.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Incoming male inmatesHIV-1 seroprevalenceIntravenous drug useType 1 infectionImmune deficiency syndromeCause of deathRisk of infectionVirus type 1Drug use variablesWestern blot techniqueCrude prevalenceRisk factorsUnivariate analysisDeficiency syndromeHIV-1Temporal trendsDrug usersDrug useExcess serumIncoming inmates